Nobelpharma Company

Nobelpharma was founded in 2003, and in 2008 we obtained our first marketing approval for an ethical drug, NOBELZIN®. We now have marketing approvals for and sell 18 new drugs and one new medical device. I
Industry: Genomic and Epigenominc Instabillity
Headquarters: Japan
Visit Website
info@nobelpharma.co.jp
Register and Claim Ownership